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Abstract 
VIPZI-Caveolin is a component of the filamentous coat surrounding the invaginations of the plasma membrane called caveolae. Unlike the vesicular 
coat proteins identified so far, VIPZl-Caveolin can be classified as an integral membrane protein. Furthermore, it is found in high molecular mass 
oligomers. Based on its localisation in specialised membrane subdomains, arole for VIP21-Caveolin in membrane protein sorting has been proposed. 
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1. Introduction 
A protein with two names in cell biology is often the ma- 
nifestation of the merging of two or more lines of research, 
and this is also the case for VIP21-Caveolin. In this 
minireview we will firstly consider the origins of both parts 
of the composite name, reflecting both research directions 
that led to the discovery of the protein, and second- 
ly the role of VIP2 1 Caveolin in the formation of caveolar 
filaments and in the sorting of glycosylphosphatidylinos- 
itol (GPI)- anchored proteins. 
2. VIP21 
VIP21 (Vesicular integral membrane protein of 21 
kDa) was identified through research into protein sort- 
ing in polarised epithelial cells [ 11. These cells have apical 
and basolateral membrane subdomains that differ in 
their protein and lipid content. The fundamental ques- 
tions of the field are: how does the polarised distribution 
of proteins occur, what are the signals for sorting and 
what is the molecular machinery involved in the sorting 
(for reviews see [2,3]). It is widely accepted that the sort- 
ing of apical and basolateral plasma membrane proteins 
occurs in the trans-Golgi network (TGN) by inclusion 
into separate vesicular carriers that transport the pro- 
teins to the correct destination [4]. 
Our experimental approach for the identification of 
components of the sorting machinery was based on a 
hypothesis postulated by Simons and his co-workers 
[5,6], predicting that glycolipids, which are enriched in 
the apical membrane are co-sorted with apical proteins 
in the TGN. Glycolipid microdomains or ‘rafts’ would 
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be the framework of budding apical vesicle: apical pro- 
teins would associate directly with these glycolipids or 
with a component of the sorting machinery. The main 
question we addressed was whether the apically destined 
influenza haemagglutinin (HA) forms specific complexes 
with specific constituents of the TGN-derived vesicles 
that had been isolated according to Bennett et al. [7,8]. 
We used the property of some membrane subdomains to be 
insoluble in particular detergents [ 11. This approach as be- 
come a powerful tool for studying protein sorting in the last 
few years. The apical marker HA becomes insoluble in TX- 
100 in the late Golgi, before its arrival at the cell surface 
[9]. Similarly, the apically targeted GPI-anchored pro- 
teins of MDCK-cells become detergent-insoluble during 
their transit through the Golgi apparatus [lo]. Treatment 
the TGN-derived vesicles with the detergent CHAPS 
yields a high-molecular-weight complex, containing in- 
fluenza HA associated with a subset of the vesicular 
proteins, including presumably those associated with 
glycolipid rafts. A cDNA encoding one of these proteins, 
VIP2 1, was isolated [I]. VIP2 1, bearing a c-myc tag, was 
localised to the Golgi apparatus, to vesicular structures 
and to the plasma membrane. In further work using anti- 
bodies raised against the N- and C-terminal domains, 
VIP21 was found in the Golgi apparatus but was also 
concentrated in the plasma membrane domains termed 
caveolae (see below) [l 11. The presence of VIP21 in both 
locations suggested that the mechanisms governing inclu- 
sion into caveolar plasma membrane domains are related 
to the processes of protein and lipid sorting at the TGN. 
3. Caveolin 
A 22 kDa protein was originally identified as one of 
the main tyrosine-phosphorylated substrates upon v-src- 
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transformation of chick embryo fibroblasts [12]. Anti- 
bodies raised against his protein [ 131 decorated caveolar 
filaments [14]. Based on this localisation, the 22 kDa 
protein was termed Caveolin and has been suggested to 
be a component of the caveolar coat. The sequence of 
chicken Caveolin is almost identical to the canine VIP21 
and the human homologue [ 15,161. 
Caveolae, or plasmalemmal vesicles [17,18], are non- 
clathrin-coated membrane invaginations of about 50 run, 
with a very characteristic striated appearance (for re- 
views see [19,20] and references therein). They are found 
on the plasma membrane of almost all types of cells. 
Although the function of caveolae has not been yet clar- 
ified, several possibilities have been postulated, including 
an alternative pathway of endocytosis, a role in receptor- 
mediated uptake of small molecules (potocytosis), in the 
regulation of intracellular calcium concentration and in 
signal transduction, 
4. Structure and properties of VIPZl-Caveolh 
VIP21-Caveolin is a protein of 178 amino acids, with 
a molecular mass of 21 kDa. VIP21Caveolin fuhils all 
the criteria required for classification as a membrane 
protein: it cannot be extracted from membranes by either 
high salt or carbonate treatment [l l] and partitions into 
the detergent phase of the TX-1 14 extract [l]. The amino 
acid sequence predicts no cleavable signal peptide but a 
single, long stretch of 33 hydrophobic residues found 
between amino acids 102 and 134. It is likely that the 
hydrophobic stretch serves as membrane anchor [l]. We 
suggested that VIP2 1 -Caveolin is a type II molecule with 
its C-terminus in the lumen of the Golgi. However, using 
antibodies produced against N- and C-terminal peptides, 
it has been demonstrated that both domains of the mol- 
ecule are accessible to the antibodies only from the cy- 
tosolic side of the membrane [111. Furthermore, using an 
in vitro translation system we have shown that VIP21- 
Caveolin associates pecifically with dog pancreas mem- 
branes in a classical, SRP-dependent manner and re- 
mains accessible to protease digestion (Monier et al., 
unpublished data). Taken together these data indicate 
that VIP21-Caveolin could form an unusual loop in the 
membrane bilayer. Although the hydrophobic stretch is 
long enough to cross the membrane twice, it does not 
contain a hydrophilic turn which usually connects two 
membrane spanning segments. It is possible that the for- 
mation of the loop structure results from the interaction 
between the regions flanking the hydrophobic stretch. It 
is also not excluded that VIP21-Caveolin does not trav- 
erse the entire bilayer and is a monotopic membrane 
protein (according to G. Blobels classification [21]). An 
example of such an integral membrane protein prosta- 
glandin H2 synthase-I which lies on the surface of the 
membrane was recently documented [22]. Three am- 
phipathic helices form a hydrophobic patch which an- 
chors the dimer in the membrane. Our model of VIP21- 
Caveolin membrane topology is in contradiction with the 
data published by Sargiacomo et al. [23]. The authors 
claim to detect surface biotinylation of VIP21-Caveolin 
in MDCK-cells using a membrane-impermeable reagent. 
To what extent a bona fide cytoplasmic protein (e.g. 
actin) was not biotinylated was not clarified. 
As an integral membrane protein, VIP2 1 -Caveolin has 
the unusual property of forming high-molecular-mass 
oligomers (Monier et al., submitted for publication). Dis- 
crete VIP2 1 Caveolin-containing complexes of 200 kDa, 
400 kDa and 600 kDa have been detected. The 400 kDa 
complex was purified to homogeneity and shown to be 
an oligomer consisting of the 21 kDa monomer exclu- 
sively. Examples of membrane proteins which form oli- 
gomers containing such a high number of monomeric 
units are quite rare and poorly understood [2426]. The 
predicted helices of the hydrophobic stretch are am- 
phipathic, which could lead to the interaction between 
two or more molecules of VIP2 1 Caveolin and hiding the 
hydrophilic residues from the lipid. 
We still do not know in what cellular compartment he 
VIP21Caveolin oligomerisation occurs and whether it is 
a regulated or reversible process. It it tempting to specu- 
late that the organisation of the glycolipid-protein mi- 
crodomains that takes place in the Golgi apparatus, and 
the VIP2 1 -Caveolin oligomerisation could be synchroni- 
sed processes. Alternatively, the oligomers could be 
found exclusively in the plasma membrane caveolae and 
the caveolar coat might then be constituted largely 
by these VIP2 1 Caveolin oligomers organised into 
filaments. Other proteins could hold the oligomers to- 
gether in the filaments or be loosely associated with 
them, as suggested by the co-immunoprecipitation of 
VIP21-Caveolin into a complex with several other pro- 
teins [27]. 
5. A function of VIP21Xaveolin in the sorting of 
GPI-anchored proteins 
GPI-anchored proteins have no membrane spanning 
domain and are held in the bilayer via a glycolipid moiety 
(for a review see [ZS]). In MDCK cells, GPI-anchored 
proteins are sorted exclusively apically [29] and the 
GPI-anchor itself can direct reporter proteins to the api- 
cal domain [30,31]. There are several observations link- 
ing caveolae with GPI-anchored proteins. One comes 
from immunofluorescence studies of the folate receptor, 
a GPI-anchored protein [32,33]. Treatment of cells with 
antibodies against this protein led to the receptors 
enrichment in caveolae. Other GPI-anchored proteins 
have also been localised to caveolae [34], although it is 
not clear yet to what extent GPI-anchored proteins are 
localised in caveolae in the absence of antibody treat- 
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Indeed, using photobleaching 
have shown that, in contrast newly arrived 
molecules, the resident pool 
MDCK cells 
[35]. 
VIP21-Caveolin, GPI-anchored proteins 
which was for the isola- 
tion VIP2 1 Caveolin, mate- 
to be quite similar [37]. Lisanti 
have demonstrated that Caveolin 
with a 
anchored protein [23]. Moreover, 
mind VIP21-Caveolin pro- 
teins some extent localised 
seem to be a manifestation 
How- 
it is clear that Golgi membranes contribute con- 
that the interaction between GPI-anchored pro- 
teins, glycolipids first in the 
Golgi apparatus. 
A further observation correlates GPI- 
anchored proteins to the apical surface with the presence 
(FRT) cells 
MDCK cells, sort 
[38], do not 
express VIP21-Caveolin in detectable quantities [39]. 
However, VIP21-Caveolin alone be responsible 
cells express VIPZl-Caveolin in 
amounts, GPI-anchored proteins also missorted 
[39]. Thus could be a necessary 
there a direct physical 
VIP2 1 Caveolin 
above makes 
tion unlikely, occur between 
lipid anchor of GPI-anchored proteins and the hydro- 
rafts 
may serve 
that other, still unidentified 
protein(s) that VIP21 -Caveolin 
VIP2 1 -Caveolin 
with an unusual membrane topology. forms 
high-molecular-mass oligomers and participates 
coat. 
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